Clinical Practice Guidance for Radiotherapy Planning After Induction Chemotherapy in Locoregionally Advanced Head-and-Neck Cancer
Joseph K. Salama(University of California San Diego), Adam S. Garden(The University of Texas MD Anderson Cancer Center), Paul M. Busse(Massachusetts General Hospital), Andy Trotti, Roy B. Tishler(Dana-Farber Cancer Institute), Robert I. Haddad(Broad Institute), Lei Dong(The University of Texas MD Anderson Cancer Center), Avraham Eisbruch(University of Michigan–Ann Arbor), Merril Kies(The University of Texas MD Anderson Cancer Center), David M. Brizel(Duke University)
International Journal of Radiation Oncology*Biology*Physics
April 13, 2009
Cited by 102
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926